STOCK TITAN

SWK Holdings Announces First Quarter 2025 Earnings Release Date and Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

SWK Holdings Corporation (SWKH), a life science-focused specialty finance company serving small- and mid-sized commercial-stage companies, has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 earnings after market close on Thursday, May 15, 2025, followed by a conference call on Friday, May 16, 2025, at 10:00am ET.

Investors can join the conference call using the dial-in numbers (888)-506-0062 for domestic callers or (973)-528-0011 for international participants, with participant code 903493. A live webcast will be available, and a replay will be accessible on the SWK Holdings website after the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-0.37%
1 alert
-0.37% News Effect

On the day this news was published, SWKH declined 0.37%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DALLAS, TX / ACCESS Newswire / May 9, 2025 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that it will issue its first quarter 2025 earnings results after the market close on Thursday, May 15, 2025. The Company will host a conference call to discuss its corporate and financial results on Friday, May 16, 2025 at 10:00am ET.

The dial-in for the conference call is (888)-506-0062 or (973)-528-0011 for international callers. The participant code is 903493. A live webcast can also be accessed through the following link: https://www.webcaster4.com/Webcast/Page/3029/52355.

A replay of the conference call will be available on the SWK Holdings website shortly following the call.

About SWK Holdings Corporation

SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. SWK's unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. SWK also owns Enteris BioPharma, a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its proprietary oral drug delivery technologies. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

For more information, please contact:

Investor Relations and Media
Susan Xu
investorrelations@swkhold.com
778-323-0959

SOURCE: SWK Holdings Corp



View the original press release on ACCESS Newswire

FAQ

When will SWK Holdings (SWKH) release its Q1 2025 earnings?

SWK Holdings will release its Q1 2025 earnings after market close on Thursday, May 15, 2025.

What time is SWK Holdings' Q1 2025 earnings conference call?

SWK Holdings' Q1 2025 earnings conference call is scheduled for Friday, May 16, 2025, at 10:00am ET.

How can investors access SWK Holdings' Q1 2025 earnings call?

Investors can dial (888)-506-0062 (domestic) or (973)-528-0011 (international) with participant code 903493, or access the live webcast through the company's website.

What type of company is SWK Holdings (SWKH)?

SWK Holdings is a life science-focused specialty finance company that caters to small- and mid-sized commercial-stage companies.
Swk Hldgs Corp

NASDAQ:SWKH

SWKH Rankings

SWKH Latest News

SWKH Latest SEC Filings

SWKH Stock Data

212.89M
11.31M
6.44%
87.36%
0.38%
Asset Management
Miscellaneous Business Credit Institution
Link
United States
DALLAS